uniQure (QURE) Operating Margin Growth (5y) (2021 - 2026)
uniQure (QURE) Operating Margin Growth (5y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 850,896.00 |
| Dec 31, 2025 | -89,382.00 |
| Sep 30, 2025 | 110,791.00 |
| Jun 30, 2025 | 165,550.00 |
| Mar 31, 2025 | 3.06 Mn |
| Dec 31, 2024 | 37,858.00 |
| Sep 30, 2024 | 123,585.00 |
| Jun 30, 2024 | 79,001.00 |
| Mar 31, 2024 | 178,202.00 |
| Dec 31, 2023 | 58,222.00 |
| Sep 30, 2023 | -508,152.00 |
| Jun 30, 2023 | -199,161.00 |
| Mar 31, 2023 | -82,939.00 |
| Dec 31, 2022 | 90,215.00 |
| Sep 30, 2022 | -369,712.00 |
| Jun 30, 2022 | -1.09 Mn |
| Mar 31, 2022 | -242,421.00 |
| Dec 31, 2021 | 18,312.00 |
| Sep 30, 2021 | -149,704.00 |
| Jun 30, 2021 | 150,615.00 |